USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	048407/0911			Pages:	28
		Recorded:	02/21/2019
Attorney Dkt #:	02950AGEN
Conveyance:	ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).

Total properties: 14

Patent #:	9089507	Issue Dt:	07/28/2015	Application #:	12442751	Filing Dt:	03/25/2009
Publication #:	US20100041585	Pub Dt:	02/18/2010
Title:	USE OF ORITAVANCIN FOR PREVENTION AND TREATMENT OF ANTHRAX

Patent #:	8518873	Issue Dt:	08/27/2013	Application #:	12676420	Filing Dt:	08/23/2010
Publication #:	US20100311646	Pub Dt:	12/09/2010
Title:	METHOD OF INHIBITING CLOSTRIDIUM DIFFICILE BY ADMINISTRATION OF ORITAVANCIN

Patent #:	9682061	Issue Dt:	06/20/2017	Application #:	12740571	Filing Dt:	05/04/2010
Publication #:	US20120035097	Pub Dt:	02/09/2012
Title:	METHODS OF TREATING BACTERIAL INFECTIONS USING ORITAVANCIN

Patent #:	8420592	Issue Dt:	04/16/2013	Application #:	13060811	Filing Dt:	04/12/2011
Publication #:	US20110201546	Pub Dt:	08/18/2011
Title:	METHODS OF TREATMENT USING SINGLE DOSES OF ORITAVANCIN

Patent #:	8901072	Issue Dt:	12/02/2014	Application #:	13389993	Filing Dt:	02/24/2012
Publication #:	US20120149632	Pub Dt:	06/14/2012
Title:	GLYCOPEPTIDE AND LIPOGLYCOPEPTIDE ANTIBIOTICS WITH IMPROVED SOLUBILITY

Patent #:	8815535	Issue Dt:	08/26/2014	Application #:	13559060	Filing Dt:	07/26/2012
Publication #:	US20130029371	Pub Dt:	01/31/2013
Title:	DISK DIFFUSION ASSAY FOR ORITAVANCIN

Patent #:	NONE	Issue Dt:		Application #:	13763799	Filing Dt:	02/11/2013
Publication #:	US20130172237	Pub Dt:	07/04/2013
Title:	METHODS OF TREATMENT USING SINGLE DOSES OF ORITAVANCIN

Patent #:	8629100	Issue Dt:	01/14/2014	Application #:	13950202	Filing Dt:	07/24/2013
Publication #:	US20130310308	Pub Dt:	11/21/2013
Title:	METHOD OF INHIBITING CLOSTRIDIUM DIFFICILE BY ADMINISTRATION OF ORITAVANCIN

Patent #:	9220749	Issue Dt:	12/29/2015	Application #:	14101645	Filing Dt:	12/10/2013
Publication #:	US20140100157	Pub Dt:	04/10/2014
Title:	METHOD OF INHIBITING CLOSTRIDIUM DIFFICILE BY ADMINISTRATION OF ORITAVANCIN

Patent #:	NONE	Issue Dt:		Application #:	14786106	Filing Dt:	10/21/2015
Publication #:	US20160101148	Pub Dt:	04/14/2016
Title:	TREATMENT AND PREVENTION OF BACTERIAL SKIN INFECTIONS USING ORITAVANCIN

Patent #:	9649352	Issue Dt:	05/16/2017	Application #:	14801303	Filing Dt:	07/16/2015
Publication #:	US20160015772	Pub Dt:	01/21/2016
Title:	HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME

Patent #:	9775878	Issue Dt:	10/03/2017	Application #:	14914773	Filing Dt:	02/26/2016
Publication #:	US20160206687	Pub Dt:	07/21/2016
Title:	METHODS FOR TREATING BACTERIAL INFECTIONS USING ORITAVANCIN AND POLYMYXINS

Patent #:	NONE	Issue Dt:		Application #:	14914792	Filing Dt:	02/26/2016
Publication #:	US20160206688	Pub Dt:	07/21/2016
Title:	METHODS FOR TREATING BACTEREMIA AND OSTEOMYELITIS USING ORITAVANCIN

Patent #:	10328118	Issue Dt:	06/25/2019	Application #:	15439206	Filing Dt:	02/22/2017
Publication #:	US20170157206	Pub Dt:	06/08/2017
Title:	HIGH PURITY ORITAVANCIN AND METHOD OF PRODUCING SAME

Assignor

Exec Dt:

01/05/2018

Assignee

300 GEORGE STREET, SUITE 301

NEW HAVEN, CONNECTICUT 06511

Correspondence name and address
	WENDEROTH, LIND & PONACK, LLP
	1030 15TH ST NW, SUITE 400 EAST
	WASHINGTON, DC 20005

Search Results as of: 05/25/2024 08:45 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6